Mechanisms and clinical implications of hepatocyte lipoapoptosis.
about
Metabolomic analysis shows differential hepatic effects of T2 and T3 in rats after short-term feeding with high fat diet.Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Enhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cellsLipase maturation factor 1 (lmf1) is induced by endoplasmic reticulum stress through activating transcription factor 6α (Atf6α) signaling.Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cellsInsulin concentration modulates hepatic lipid accumulation in mice in part via transcriptional regulation of fatty acid transport proteins.Mechanisms of lipotoxicity in NAFLD and clinical implicationsLipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic liversEicosapentaenoic acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient miceCell death and cell death responses in liver disease: mechanisms and clinical relevanceLoss of ULK1 increases RPS6KB1-NCOR1 repression of NR1H/LXR-mediated Scd1 transcription and augments lipotoxicity in hepatic cellsAn in vitro model of human acute ethanol exposure that incorporates CXCR3- and CXCR4-dependent recruitment of immune cellsMetabolomic profiling reveals a role for caspase-2 in lipoapoptosisGlycycoumarin inhibits hepatocyte lipoapoptosis through activation of autophagy and inhibition of ER stress/GSK-3-mediated mitochondrial pathway.Early cytokine signatures of ischemia/reperfusion injury in human orthotopic liver transplantation.Casein Glycomacropeptide Hydrolysates Exert Cytoprotective Effect against Cellular Oxidative Stress by Up-Regulating HO-1 Expression in HepG2 Cells.Translational and posttranslational regulation of XIAP by eIF2α and ATF4 promotes ER stress-induced cell death during the unfolded protein response.Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance.Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.Inflammation and fibrogenesis in steatohepatitis.Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease.Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis.Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention.c-Jun N-terminal kinase-mediated Rubicon expression enhances hepatocyte lipoapoptosis and promotes hepatocyte ballooning.Degradation of cIAPs contributes to hepatocyte lipoapoptosis.Secretion of triacylglycerol-poor VLDL particles from McA-RH7777 cells expressing human hepatic lipase.Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model.Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.Role of mitochondria and mitochondria targeted agents in non-alcoholic fatty liver disease.Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol-induced hepatocyte steatosis and apoptosis.The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease.Plasma free myristic acid proportion is a predictor of nonalcoholic steatohepatitis.HIF-1α expression as a protective strategy of HepG2 cells against fatty acid-induced toxicity.Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.
P2860
Q33700432-299347AE-69F0-4827-BDE6-3079D75EFCD7Q33755829-08104161-9A1B-4F56-8807-52FDD5A7E62FQ33825109-7A58D8DB-52C8-4198-A911-37C89453C2A4Q34107296-B8E48BD7-59C9-494E-8E3C-E2720B1D8785Q34152594-A3E64417-ECA0-427F-82D2-E725B760DC09Q34321195-BF04742E-A2DA-430B-9033-C8E1152B76CCQ35132916-85B28A68-0A64-47F7-B876-A902AD5377FDQ35172447-23652BCF-7F07-4FFE-A33A-C39A95CE9A9EQ35588868-F5A78C10-B82A-4B60-91EB-DE501A0BD3B5Q35938040-FA384431-1F30-4503-A902-1939F7D0B188Q36193081-CEE2B691-A846-4B50-BBE8-6B4763A632D0Q36620481-30951E72-53D5-4481-B2CF-7E3AE8EDC097Q36850355-BB2FD525-00C5-4A1C-8FD8-741167D6893EQ37454201-66460F0B-FDB5-4AFA-80CA-822995FF600FQ37469221-292EE63C-12ED-40D6-B8EE-258208B4056BQ37628363-0FE62AEC-70D3-4CCD-B7FD-A2916C9E4850Q37732157-A03DD11E-234D-4E8B-A659-B94F062BC2DEQ37863134-45FAAF75-AA9E-4E86-BA57-436A93FA7F9BQ37973510-CD2475DB-0ACA-44D0-9BEA-2F012D95CE03Q37976341-96945872-9121-48E1-B88F-DBB840202F38Q37981867-5F629870-C190-4D22-AC93-C06B64F5D0F1Q38178585-BE5B8927-C81E-4546-B2DE-EE84F9697D80Q38522663-D9F2F3B2-629B-48D3-83CB-CD79374F2503Q38584060-40D11205-E150-4614-B446-B602E6E85E3AQ38747634-9F382929-0901-434A-95F2-F2BC3273C963Q39099740-6C18CFAB-02F8-4D6B-9CA3-3543DEAFF178Q39614897-5DAFB42B-C5D4-49AA-9417-30A396E131DCQ41761778-1904B890-59E6-4A10-92DA-6DD3626C3281Q42934583-E546B0F0-B987-442B-830E-3FAEAB914C8CQ46266754-8DE5077B-D869-405A-A572-40F8CDAF2F07Q46366543-44E6A841-0D58-42DC-B081-FF15B9AF5830Q46606052-1B28DB99-CEB0-4147-A9D9-92D9913C8172Q51374620-1F060119-01B3-4D2F-B599-546E013BA028Q51760102-1DF19C11-5961-4C57-984E-F6AF8DE9D9C8Q54317961-2C45B43B-D0D2-4594-BC97-157621ACF198
P2860
Mechanisms and clinical implications of hepatocyte lipoapoptosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Mechanisms and clinical implications of hepatocyte lipoapoptosis.
@en
Mechanisms and clinical implications of hepatocyte lipoapoptosis.
@nl
type
label
Mechanisms and clinical implications of hepatocyte lipoapoptosis.
@en
Mechanisms and clinical implications of hepatocyte lipoapoptosis.
@nl
prefLabel
Mechanisms and clinical implications of hepatocyte lipoapoptosis.
@en
Mechanisms and clinical implications of hepatocyte lipoapoptosis.
@nl
P2860
P356
P1433
P1476
Mechanisms and clinical implications of hepatocyte lipoapoptosis.
@en
P2093
Sophie C Cazanave
P2860
P356
10.2217/CLP.09.85
P577
2010-02-01T00:00:00Z